You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Integrin ανβ3

Showing 1 - 25 of 297
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Assessment of Integrin Expression in Endometriosis

Enrolling by invitation
  • Endometriosis
  • Maraciclatide
  • Oxford, Oxon, United Kingdom
    John Radcliffe Hospital
Nov 14, 2022

Miscarriage, Recurrent Trial in Kuala Lumpur (GNRH Analoge, Duphaston, Letrozole)

Completed
  • Miscarriage, Recurrent
  • GNRH Analoge, Duphaston, Letrozole
  • Kuala Lumpur, Malaysia
    UniversitiKMMC
Jun 24, 2022

Tumor, Solid, Positron-Emission Tomography Trial in Xiamen (18F-FDG PET/CT, 68Ga-FAPI-RGD PET/CT)

Recruiting
  • Tumor, Solid
  • Positron-Emission Tomography
  • 18F-FDG PET/CT, 68Ga-FAPI-RGD PET/CT
  • Xiamen, Fujian, China
    The First Affiliated Hospital of Xiamen University
Sep 16, 2022

Lung Cancer, Neuroendocrine Tumor Trial in Beijing (68Ga-NOTA-3P-TATE-RGD)

Recruiting
  • Lung Cancer
  • Neuroendocrine Neoplasm
  • Beijing, Beijing, China
    Peking Union Medical College Hospitall, Chinese Academy of Medic
Mar 30, 2022

Renal Tumor Trial

Not yet recruiting
  • Renal Tumor
    • (no location specified)
    Aug 2, 2023

    Breast Tumors Trial

    Not yet recruiting
    • Breast Tumors
      • (no location specified)
      Aug 2, 2023

      Rheumatoid Arthritis Trial

      Not yet recruiting
      • Rheumatoid Arthritis
        • (no location specified)
        Jul 6, 2023

        Tumors Trial in Chengdu

        Recruiting
        • Neoplasms
          • Chengdu, Sichuan, China
            Departments of Nuclear Medicine, Sichuan Provincial People's Hos
          Oct 16, 2023

          18F-FAPI-RGD in Interstitial Lung Disease Associated With

          Recruiting
          • Interstitial Lung Disease
            • Chengdu, Sichuan, China
              Sichuan Provincial People's Hospital
            Nov 21, 2023

            Advanced Pancreatic Cancer, Solid Tumor Malignancies Trial run by the (ProAgio)

            Recruiting
            • Advanced Pancreatic Cancer
            • Solid Tumor Malignancies
            • Bethesda, Maryland
              National Cancer Institute
            Sep 26, 2022

            Lung Cancer Metastatic Trial in China (99mTc-3PRGD2)

            Completed
            • Lung Cancer Metastatic
            • Beijing, Beijing, China
            • +3 more
            Apr 25, 2022

            Pancreatic Cancer, Solid Tumors Trial run by the NCI (ProAgio)

            Not yet recruiting
            • Pancreatic Cancer
            • Solid Tumors
            • Bethesda, Maryland
              National Institutes of Health Clinical Center
            Jun 26, 2021

            Metastatic Colorectal Cancer Trial (abituzumab, Placebo + Cetuximab + FOLFIRI)

            Withdrawn
            • Metastatic Colorectal Cancer
            • (no location specified)
            Mar 16, 2020

            Pancreatic Ductal Adenocarcinoma, Gastroesophageal Adenocarcinoma, Glioblastoma Multiforme Trial (68Ga-FF58, 177Lu-FF58)

            Not yet recruiting
            • Pancreatic Ductal Adenocarcinoma
            • +2 more
            • (no location specified)
            Jul 28, 2023

            Idiopathic Pulmonary Fibrosis, Primary Sclerosing Cholangitis, Covid19 Pneumonia Trial in Stanford ([18F]FP-R01-MG-F2)

            Recruiting
            • Idiopathic Pulmonary Fibrosis
            • +2 more
            • Stanford, California
              Stanford University
            May 3, 2022

            Healthy Subject, Pancreatic Carcinoma Trial in Palo Alto (diagnostic test, other, drug)

            Active, not recruiting
            • Healthy Subject
            • Pancreatic Carcinoma
            • Computed Tomography
            • +3 more
            • Palo Alto, California
              Stanford University, School of Medicine
            Apr 8, 2022

            Pancreas Cancer Trial (mRNA expression)

            Not yet recruiting
            • Pancreas Cancer
            • mRNA expression
            • (no location specified)
            Aug 8, 2022

            Vitiligo Trial in Cairo (Narrow band UVB)

            Active, not recruiting
            • Vitiligo
            • Narrow band UVB
            • Cairo, El Manial, Egypt
              Kasr El Ainy university hospital, Faulty of medicine,Cairo unive
            Mar 10, 2022

            Diagnosis and Clinical Management of Angiogenic Breast Cancer Trial in Chandigarh, New Delhi, Johannesburg (Ga-68-PEG-?vß3-IAC

            Not yet recruiting
            • Diagnosis and Clinical Management of Angiogenic Breast Cancer
            • Ga-68-PEG-Αvβ3-IAC PET/CT
            • Chandigarh, India
            • +2 more
            May 27, 2022

            Coronary Artery Disease Trial in Turku, Leiden, Lausanne (68Ga-NODAGA-RGD PET-imaging)

            Recruiting
            • Coronary Artery Disease
            • 68Ga-NODAGA-RGD PET-imaging
            • Turku, Finland
            • +2 more
            Mar 20, 2022

            Keloid Trial in Beijing (68Ga-FAPI, (68)Ga-RGD)

            Recruiting
            • Keloid
            • Beijing, Beijing, China
              Peking Union Medical College Hospital
            Mar 2, 2022

            Lung Tumors Trial in Beijing (68Ga-FAPI-RGD, 18F-FDG, 68Ga-FAPI)

            Recruiting
            • Lung Neoplasms
            • Beijing, China
              Peking Union Medical College Hospital
            Sep 13, 2022

            EMBRYO IMPLANTATION Trial in Mansoura (Letrozole 2.5Mg Tablet, Gonadotropins, endometrial sample in the pretreatment cycle)

            Unknown status
            • EMBRYO IMPLANTATION
            • Letrozole 2.5Mg Tablet
            • +2 more
            • Mansoura, Egypt
              Mansoura University
            Dec 13, 2019

            Epidermolysis Bullosa Trial in Minneapolis (drug, procedure, radiation)

            Active, not recruiting
            • Epidermolysis Bullosa
            • Minneapolis, Minnesota
              University of Minnesota Masonic Cancer Center and Medical Center
            Feb 25, 2022

            Integrin avß6-targeted PET in Malignant Tumors

            Recruiting
            • Malignant Neoplasm
            • +2 more
              • Wuhan, Hubei, China
                Zhongnan Hospital of Wuhan University
              Apr 18, 2023